The IHC signals for NDUFA4L2 and ANKRD45 were stronger in tumor tissue treated with CUMS, while AQP3 expression was weaker compared to the control (Figure 5B,C), and the mRNA levels of signature genes are consistent with the IHC results (Figure 5D). The gene discussed is ANKRD45; the disease is neoplasm.